Adenosine deaminase inhibitors: Synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R-nonyl)adenine [(+)-EHNA]

Journal of Medicinal Chemistry

Volumn 43, Issue 24, 2000, Pages 4694-4700

  Pragnacharyulu, P V P ^a   Varkhedkar, V ^a   Curtis, M A ^a   Chang, I F ^a   Abushanab, E ^a  

^a University of Rhode Island   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE INHIBITOR; ERYTHRO 9 (2' HYDROXY 3' NONYL)ADENINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION;

ADENINE; ADENOSINE DEAMINASE; ANIMALS; CATTLE; ENZYME INHIBITORS; INTESTINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034736035     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0002533     Document Type: Article

References (33)

1. Hypnotic effects of deoxycoformycin in rats
2. Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase
3. Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flow
4. Modulation of platelet functions by plasma adenosine levels
5. 31P nuclear magnetic resonance
6. Protective effects of an adenosine deaminase inhibitor on ischemia - Reperfusion injury in isolated perfused rat heart
7. Deoxycoformycin and oxypurinol: Protection against focal ischemic brain injury in the rat
8. Chronic lymphoproliferative disorders: Chronic lymphocytic leukemia and hairy cell leukemia
9. Helper-suppressor T-cell leukemia: Unusual phenotype controlled with low dose deoxycoformycin
10. Coformycin and deoxycoformycin: Tight-binding inhibitors of adenosine deaminase
11. Metabolism and anti-human immunodeficiency virus-1 activity of 2-Halo-2',3'-dideoxyadenosine derivatives
12. Transition-state stabilization by adenosine deaminase: 1,6-Addition of water to purine ribonucleoside, the enzyme's affinity for 6-hydroxy-1,6-dihydropurine ribonucleoside, and the effective concentration of substrate water at the active site
13. Tight-binding inhibitors-IV. Inhibition of adenosine deaminases by various inhibitors
14. Recovery of 2'-deoxycoformycin inhibited adenosine deaminase of mouse erythrocytes and leukemia L1210 in vivo
15. 14C]adenine in the Rhesus Monkey
16. Inhibition of Adenosine Deaminase (ADA) in vivo in CBA-J Mice by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) and its metabolic consequences
17. Enzyme inhibitors: 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines
18. Identification of the bioactive enantiomer of erythro-3-(adenin-9-yl)-2-nonanol (EHNA), a semi-tight binding inhibitor of adenosine deaminase
19. Synthesis of inhibitors of adenosine deaminase. A total synthesis of erythro-3-(adenin-9-yl)-2-nonanol and its isomers from chiral precursors
20. Adenosine deaminase inhibitors. Conversion of a single chiral synthon into erythro and threo-9-(2-hydroxy-3-nonyl)adenines
21. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) on adenosine deaminase inhibition
22. Design and evaluation of enzyme inhibitors, especially of adenosine deaminase
23. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and Nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine
24. Adensine deaminase inhibitors. Synthesis and biological evaluation of 4-Amino-1-(2(S)-hydroxy-3(R)-nonyl)-1H-imidazo[4,5-c]pyridine (3-Deaza (+)-EHNA) and certain C1' derivatives
25. Adenosine deaminase inhibitors. Synthesis and biological evaluation of putative metabolites of (+)-erythro-9-(2(S)-hydroxy-3(R)-(nonyl)adenine
26. Regulation of adenosine concentration and cytoprotective. Effects of novel reversible adenosine deaminase inhibitors
27. Atomic structure of adenosine deaminase complexed with a transition-state analog: Understanding catalysis and immunodeficiency mutations
28. Adenosine deaminase inhibitors. Synthesis and biological evaluation of chain modified analogues of (+)-EHNA
29. Adenosine deaminase inhibitors. Synthesis and biological evaluation of Aralkyladenines (ARADs)
30. The chemistry of L-ascorbic and D-isoascorbic acids. 1. The preparation of chiral butanetriols and -tetrols
31. Synthesis of the optically active α-nucleic acid base substituted propanoic acids
32. Screening solution phase combinatorial libraries using pulsed ultrafiltration/electrospray mass spectroscopy
33. Transmetallation and double metal exchange: A convenient route to organolithium compounds of the benzyl and allyl type